Shionogi & Co.,Ltd. Logo

Shionogi & Co.,Ltd.

A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.

4507 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市中央区道修町3丁目1番8号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Shionogi & Co., Ltd. is a research-driven pharmaceutical company focused on the discovery, development, manufacturing, and marketing of pharmaceuticals, diagnostic reagents, and medical devices. With a history of over 140 years, the company is dedicated to creating innovative products and services that deliver value to patients and society globally. As a drug discovery-based organization, Shionogi leverages its robust research and development pipeline to address unmet medical needs and contribute to the health of people worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-19 09:24
Post-Annual General Meeting Information
臨時報告書
Japanese 30.7 KB
2025-06-19 09:14
Governance Information
内部統制報告書-第160期(2024/04/01-2025/03/31)
Japanese 30.2 KB
2025-06-19 09:12
Registration Form
確認書
Japanese 8.9 KB
2025-06-19 09:10
Annual Report
有価証券報告書-第160期(2024/04/01-2025/03/31)
Japanese 2.5 MB
2025-06-19 08:07
M&A Activity
公開買付報告書
Japanese 41.6 KB
2025-06-19 06:40
Major Shareholding Notification
大量保有報告書
Japanese 61.0 KB
2025-06-18 08:49
Share Issue/Capital Change
臨時報告書
Japanese 41.9 KB
2025-06-04 08:39
Regulatory News Service
訂正公開買付届出書
Japanese 258.4 KB
2025-05-28 08:38
M&A Activity
訂正公開買付届出書
Japanese 262.0 KB
2025-05-08 05:52
Regulatory News Service
公開買付届出書
Japanese 530.2 KB
2025-05-07 09:12
M&A Activity
臨時報告書
Japanese 50.3 KB
2024-11-08 02:44
Interim Report
確認書
Japanese 9.0 KB
2024-11-08 02:41
Interim Report
半期報告書-第160期(2024/04/01-2025/03/31)
Japanese 320.3 KB
2024-06-21 08:18
Post-Annual General Meeting Information
臨時報告書
Japanese 27.6 KB
2024-06-21 04:28
Governance Information
内部統制報告書-第159期(2023/04/01-2024/03/31)
Japanese 24.1 KB

Automate Your Workflow. Get a real-time feed of all Shionogi & Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Shionogi & Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland LONN
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway LYTIX
MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland MAB
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden MAGLE
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany N/A
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria MARI
Matricelf Ltd. Logo
Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.
Israel MTLF
Median Diagnostics Inc. Logo
Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.
South Korea 233250
MediciNova,Inc. Logo
Developing small-molecule drugs for neurology, respiratory, and liver diseases.
Japan 4875

Talk to a Data Expert

Have a question? We'll get back to you promptly.